首页> 美国卫生研究院文献>Clinical Molecular Pathology >A study of two methods for estimating plasma fibrinogen and the effect of epsilon aminocaproic acid and protamine
【2h】

A study of two methods for estimating plasma fibrinogen and the effect of epsilon aminocaproic acid and protamine

机译:估计血浆纤维蛋白原的两种方法以及ε-氨基己酸和鱼精蛋白作用的研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Fibrinogen concentrations were determined in normal plasma and in plasma from patients with high and low levels. There was a good correlation between the results of a rapid semi-quantitative fibrinogen titre technique and those of a quantitative assay of coagulable fibrinogen. In normal subjects fibrinogen levels were not significantly influenced by taking blood into epsilon aminocaproic acid (EACA) or by the addition of protamine to plasma. In patients with the defibrination syndrome in whom increased plasma fibrinolysis was not detected, fibrinogen levels were not affected by taking blood into EACA but considerably increased levels were observed after the addition of protamine to plasma. In patients undergoing thrombolytic therapy the fibrinogen levels measured were increased both in blood taken into EACA and in plasma containing protamine. It is suggested that EACA acted by preventing lysis in vitro whilst protamine counteracted abnormal fibrin polymerization. The pattern of results may be of diagnostic importance.
机译:在正常血浆和高血脂和低血脂患者的血浆中测定纤维蛋白原浓度。快速半定量纤维蛋白原滴定技术的结果与可凝固纤维蛋白原定量分析的结果之间具有良好的相关性。在正常受试者中,通过将血液注入ε氨基己酸(EACA)或向血浆中添加鱼精蛋白对血纤蛋白原水平没有显着影响。在未检测到血浆纤维蛋白溶解增加的去纤维化综合征患者中,将血液注入EA​​CA不会影响纤维蛋白原水平,但是在血浆中添加鱼精蛋白后观察到水平显着升高。在接受溶栓治疗的患者中,进入EACA的血液和含有鱼精蛋白的血浆中测得的纤维蛋白原水平均升高。提示EACA通过阻止体外裂解而起作用,而鱼精蛋白则抵消了异常的纤维蛋白聚合反应。结果的模式可能具有诊断重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号